Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aukrust

Showing results (811-820 of 910) with videos related to

Pageof 91
Sort By:
Scientific Reports|January 19, 2019
Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiencyS F Jørgensen, M E Macpherson, T Bjørnetrø, et al.
Frontiers in Cardiovascular Medicine|March 13, 2026
Platelet-derived mediators in hospitalized COVID-19 patients and associations to respiratory failure, ICU admittance and 60-day mortalityKari Otterdal, Thor Ueland, Jan Cato Holter, et al.
Journal of Neuroimmunology|April 10, 2014
Increasing serum levels of vitamin A, D and E are associated with alterations of different inflammation markers in patients with multiple sclerosisEgil Røsjø, Kjell-Morten Myhr, Kristin Ingeleiv Løken-Amsrud, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 8, 2019
Increased Complement Factor B and Bb Levels Are Associated with Mortality in Patients with Severe Aortic StenosisNegar Shahini, Thor Ueland, Andreas Auensen, et al.
Communications Medicine|October 4, 2023
The use of precision diagnostics for monogenic diabetes: a systematic review and expert opinionRinki Murphy, Kevin Colclough, Toni I Pollin, et al.
Journal of Neuroimmunology|March 17, 2015
Vitamin D status and effect of interferon-β1a treatment on MRI activity and serum inflammation markers in relapsing-remitting multiple sclerosisEgil Røsjø, Kjell-Morten Myhr, Kristin I Løken-Amsrud, et al.
Trials|November 6, 2025
Randomized trial of nirmatrelvir/ritonavir versus placebo for adults with acute COVID-19 to prevent long COVID: PanoramicNOR TrialBjørn Blomberg, Nikolai Norevik Myklebust, Oddvar Oppegaard, et al.
Atherosclerosis|September 25, 2015
Increased expression of NAMPT in PBMC from patients with acute coronary syndrome and in inflammatory M1 macrophagesBente Halvorsen, Martine Z Espeland, Geir Øystein Andersen, et al.
Circulation. Heart Failure|September 23, 2020
YKL-40 (Chitinase-3-Like Protein 1) Serum Levels in Aortic StenosisFizza Arain, Aurelija Abraityte, Mariia Bogdanova, et al.
Platelets|February 28, 2022
Anti-PF4/polyanion antibodies in COVID-19 patients are associated with disease severity and pulmonary pathologyThor Ueland, Ingvild Hausberg, Trude Victoria Mørtberg, et al.
Pageof 91

Showing results (811-820 of 910) with videos related to

Sort By:
Pageof 91
Scientific Reports|January 19, 2019
Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiencyS F Jørgensen, M E Macpherson, T Bjørnetrø, et al.
Frontiers in Cardiovascular Medicine|March 13, 2026
Platelet-derived mediators in hospitalized COVID-19 patients and associations to respiratory failure, ICU admittance and 60-day mortalityKari Otterdal, Thor Ueland, Jan Cato Holter, et al.
Journal of Neuroimmunology|April 10, 2014
Increasing serum levels of vitamin A, D and E are associated with alterations of different inflammation markers in patients with multiple sclerosisEgil Røsjø, Kjell-Morten Myhr, Kristin Ingeleiv Løken-Amsrud, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 8, 2019
Increased Complement Factor B and Bb Levels Are Associated with Mortality in Patients with Severe Aortic StenosisNegar Shahini, Thor Ueland, Andreas Auensen, et al.
Communications Medicine|October 4, 2023
The use of precision diagnostics for monogenic diabetes: a systematic review and expert opinionRinki Murphy, Kevin Colclough, Toni I Pollin, et al.
Journal of Neuroimmunology|March 17, 2015
Vitamin D status and effect of interferon-β1a treatment on MRI activity and serum inflammation markers in relapsing-remitting multiple sclerosisEgil Røsjø, Kjell-Morten Myhr, Kristin I Løken-Amsrud, et al.
Trials|November 6, 2025
Randomized trial of nirmatrelvir/ritonavir versus placebo for adults with acute COVID-19 to prevent long COVID: PanoramicNOR TrialBjørn Blomberg, Nikolai Norevik Myklebust, Oddvar Oppegaard, et al.
Atherosclerosis|September 25, 2015
Increased expression of NAMPT in PBMC from patients with acute coronary syndrome and in inflammatory M1 macrophagesBente Halvorsen, Martine Z Espeland, Geir Øystein Andersen, et al.
Circulation. Heart Failure|September 23, 2020
YKL-40 (Chitinase-3-Like Protein 1) Serum Levels in Aortic StenosisFizza Arain, Aurelija Abraityte, Mariia Bogdanova, et al.
Platelets|February 28, 2022
Anti-PF4/polyanion antibodies in COVID-19 patients are associated with disease severity and pulmonary pathologyThor Ueland, Ingvild Hausberg, Trude Victoria Mørtberg, et al.
Pageof 91